title: [Functional state of the hemostasis system in patients, operated for pancreatic pseudocysts].
abstract: Operative treatment of pancreatic pseudocysts coincides with the indices of the blood coagulation system change, which are characterized as a hypercoagulative. These disorders are noted in 12-24 h postoperatively, their rate is reducing substantially while application of pentoxyphylline. Most significant lowering of intraoperative hypercoagulation was noted while application of endoscopic drainage with the pseudocysts cavity stenting.
authors: B S
authors: BS
authors: Zaporozhchenko
authors: V G
authors: VG
authors: Shevchenko
authors: O B
authors: OB
authors: Zubkov
authors: I E
authors: IE
authors: Borodaev
authors: A A
authors: AA
authors: Gorbunov
mesh_terms: D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D002760:Cholangiopancreatography, Endoscopic Retrograde; D004322:Drainage / Q000379:methods; D016145:Endoscopy, Digestive System; D005260:Female; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010192:Pancreatic Pseudocyst / Q000000981:diagnostic imaging / Q000601:surgery*; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D010976:Platelet Count; D015607:Stents; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D010975:Platelet Aggregation Inhibitors; D010431:Pentoxifylline